Cargando…
Inhibition of Chk1 with the small molecule inhibitor V158411 induces DNA damage and cell death in an unperturbed S-phase
Chk1 kinase is a critical component of the DNA damage response checkpoint and Chk1 inhibitors are currently under clinical investigation. Chk1 suppresses oncogene-induced replication stress with Chk1 inhibitors demonstrating activity as a monotherapy in numerous cancer types. Understanding the mecha...
Autores principales: | Wayne, Joanne, Brooks, Teresa, Massey, Andrew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356717/ https://www.ncbi.nlm.nih.gov/pubmed/27829224 http://dx.doi.org/10.18632/oncotarget.13119 |
Ejemplares similares
-
An ATR and CHK1 kinase signaling mechanism that limits origin firing during unperturbed DNA replication
por: Moiseeva, Tatiana N., et al.
Publicado: (2019) -
Modification of tumour cell metabolism modulates sensitivity to Chk1 inhibitor-induced DNA damage
por: Massey, Andrew J.
Publicado: (2017) -
Regulation of Unperturbed DNA Replication by Ubiquitylation
por: Priego Moreno, Sara, et al.
Publicado: (2015) -
Inhibition of the checkpoint kinase Chk1 induces DNA damage and cell death in human Leukemia and Lymphoma cells
por: Bryant, Christopher, et al.
Publicado: (2014) -
Checkpoint Kinase 1 (Chk1) inhibition fails to activate the Stimulator of Interferon Genes (STING) innate immune signalling in a human coculture cancer system
por: Brooks, Teresa, et al.
Publicado: (2021)